Overview

N-acetyl-cysteine (NAC) and Kidney Graft Function

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

The goal of this study is to evaluate the effect of N-acetyl-cysteine (NAC) administration in organ donors on the kidney graft function of recipients.

Phase:

Phase 3

Details

Lead Sponsor:

Institut d'Anesthesiologie des Alpes Maritimes

Treatments:

Acetylcysteine
N-monoacetylcystine